The Elder Law Firm of Marshall & Associates
Contact Us Meet Our Staff Articles Of Interest Long Term Care Planning Estate Planning Our Newsletters


Search PAElderLaw.com
 

The Elder Care Law Alert

Marshall & Associates' E-mail Newsletters

2004

 

Elder Care Law Alert

                                January 26th, 2004 Issue 

_________________________________________

Jersey Shore, Williamsport, Wilkes-Barre

1-800-401-4552

www.paelderlaw.com 

________________________________

The Elder Law Firm of Marshall & Associates is a recognized leader in providing coordinated legal and elder care planning services to older adults and their families throughout Pennsylvania.

__________________________________________

In this Issue

1.  The Medicare Act of 2003, Part 2:

An Outline of the Prescription Coverage which begins in 2006

 A.  Private Prescription Drug Plans: PDPs and MA-PDs

  B.  Standard (Basic) Part D Coverage

  C.  Subsidies for Medicaid and Low Income Recipients

  D.  Effects on Medigap Insurance Policies

   E.  Effects on PACE/PACENET


The Medicare Act of 2003, Part 2:

An Outline of the Prescription Coverage which begins in 2006

Written By: Attorney Jeffrey A. Marshall , CELA*

The Elder Care Law Alert (ECLA) is providing readers with an ongoing analysis of the major provisions of the new Medicare Act (The Medicare Prescription Drug, Improvement, and Modernization Act of 2003).  The Act adds a Medicare prescription drug benefit, replaces the Medicare+Choice program with a new program called "Medicare Advantage," and makes many other changes that will influence the health care provided to seniors in America .  A recent Elder Care Law Alert covered discount cards and other changes that will take effect before 2006.  This issue will give an overview of the prescription drug benefit that will begin in 2006.

Private Prescription Drug Plans: PDPs and MA-PDs

Beginning in 2006, all Medicare beneficiaries who are entitled to Part A or enrolled in Part B will be able to sign-up for optional Medicare authorized prescription drug coverage.  About 41 million Americans will have this option.  The drug coverage will not be provided directly by Medicare, but will be offered by private companies who will be subsidized by the government.

Medicare recipients will be able to obtain Medicare drug coverage through one of two paths: 

(1) Beneficiaries who are enrolled in a Medicare Advantage (MA) Plan that offers prescription drug coverage (an MA-PD plan) will get their coverage through that plan.  Medicare Advantage is the new name the government is giving to Medicare managed care plans (HMOs/PPOs); they will be the successors to the current Medicare+Choice plans and will operate under Medicare Part C.

(2) Beneficiaries who remain in traditional Medicare, or whose managed care plan does not offer drug coverage, will be able to sign up for a stand-alone prescription drug plan (PDPs), which will operate under the new Medicare Part D.

All PDP and MA-PD plans must offer at least standard basic drug coverage or its actuarial equivalent.  In any geographic area that lacks at least two plan options, the government will offer standard benefits through a fall-back plan.  The initial enrollment period will commence on November 15, 2005 and coverage will begin on January 1, 2006 .  Once individuals select a plan, they will generally be locked into it for the year.  

Consumers will need to choose among the different plans available in their geographic region.  Plans will be able to have different formularies (lists of covered drugs) and will be able to charge different premiums and co-payments so long as they are actuarially equivalent to a standard plan.  While plans will be required to meet government guidelines by providing drugs in each established "therapeutic class," each plan may vary as to the specific drugs it covers.  Seniors will have to shop carefully to ensure that the plan they choose provides the best coverage for the specific drugs they are taking.      

In a much criticized provision, the Medicare Act of 2003 actually prohibits the Government from using its immense bargaining power to negotiate discounts on drug prices from pharmaceutical companies.  Instead, each individual plan will have to use its more limited bargaining power to negotiate discounts from drug manufacturers.  The Act also enhances the potential for inflation in drug prices by restricting the re-importation of drugs from Canada .   

Standard (Basic) Part D Coverage

Medicare coverage will apply to drugs, biological products and insulin that may be dispensed only by prescription and that would normally be covered by Medicaid.  Excluded are drugs that are covered under Medicare Parts A or B, those excluded by Medicaid, and non-prescription drugs.  Only drugs that are chosen by the consumer's chosen plan for inclusion in its formulary will be covered.  

In 2006, the consumer will be solely responsible for the first $250 of covered drug costs (the deductible). The plan will then pay 75% of the next $2,000 in drug costs.  $2,250 is the initial coverage limit.  There is no coverage between $2,250 and $5,100 (the so-called "doughnut hole").  This means that the consumer will receive no additional insurance reimbursement until he or she has paid a total of $3,600 out of pocket for drugs that are covered by the plan.  If the consumer eventually incurs $5,100 in total covered annual drug expenses, the catastrophic aspect of the coverage kicks in.  After that point, the insurance picks up 95% of the covered costs.   

Drug plans will be authorized to vary from this basic coverage so long as they offer a benefit package that is deemed to be "actuarially equivalent" (of the same value).  The basic insurance thresholds will be indexed to the per capita growth in Part D spending. As a result, it is estimated that by 2013 the deductible will rise to $445 and the initial coverage limit will increase to $4,000.

Drug plans will be independently permitted to develop formularies of the drugs they will cover. They will be allowed to change the specific drugs that will be covered by their plans from time to time.  The existence of differing formularies may make it difficult for seniors to determine which plan will provide them with the best coverage.  However, once consumers have chosen a plan, they must stick with that plan for the entire year.  Consumers whose medication needs changed during the year may easily be stuck in a plan that provides poor coverage. Each plan will be required to have an appeal process, but doctors are precluded from filing an appeal on a patient's behalf.   

Drug costs count towards the coverage thresholds only if paid by the plan participant (or by another family member on behalf of the participant), or paid by the subsidy for low income individuals (see below), or by a state pharmaceutical assistance program.  This means that any costs for which the participant is reimbursed by insurance or otherwise will not count.  

The law also specifies that costs the consumer incurs for drugs which are not included in the plan's formulary do not count towards the catastrophic coverage threshold.  So, consumers whose plan does not include their drug of choice will feel enormous pressure to switch to a covered drug.  

Premiums

Persons desiring to enroll in a PDP plan will have to pay a monthly premium with an estimated average cost in 2006 of about $35 per month.  The actual premium amount may vary by plan.  This monthly fee is in addition to the Part B premium, so seniors who enroll will have over $100 per month in Medicare premiums deducted from their social security. The Part D premium is intended to represent, on average, 26% of the cost of the benefit being provided.  Late enrollment penalties may apply to some individuals who delay their enrollment. 

Beneficiaries will be able to pay their monthly premiums directly to the PDP or MA-PD plan or have them electronically transferred.  However, most seniors will probably choose to have the premiums deducted from their monthly social security payment.  Premiums go to the plan, not to the government. 

Premiums can be waived for some beneficiaries with low incomes (see below).

Some Coverage/Cost Examples

Here are examples of how the Part D coverage and out of pocket costs should work for some individuals in 2006:

The Average Senior:  According to the Kaiser Family Foundation, the average senior will have $3,160 (about $263 per month) in annual drug expenses in 2006.  If that average senior enrolls in a PDP, his or her out-of-pocket cost could be reduced to $2,080 ($1,660 plus $420 in premiums), if only drugs which are covered are purchased. This could result in savings of $1,080 or about 34% of the covered drug costs.   

The Low Drug Expenditure Senior:

Due to the premiums, deductibles, and co-pays, seniors with low drug costs of under $800 per year will actually end up spending more if they enroll in a Part D plan.  However, it is likely that most seniors will elect to participate in the drug coverage since it will give them the assurance of having catastrophic coverage in the event of an unforeseen illness. 

The High Drug Expenditure Senior:

An individual with $500 a month ($6,000 per year) in covered prescription drug costs will end up spending $4,065 ($3,645 plus $420 in premiums). This savings of $1,935 amounts to approximately 32% of covered drug costs.  

Seniors with truly catastrophic drug costs will potentially benefit greatly from Part D coverage.  In 2006, seniors will have to pay $3,600 for their first $5,100 of covered prescriptions plus the monthly premiums, estimated at $420 for the first year. After that, Medicare will cover 95 percent of the cost of each prescription.  Thus, an individual with $900 a month ($10,800 per year) in covered drug costs will end up spending $4,305 ($3,885 plus $420 in premiums) and achieve a savings of $6,595 or 61%.

Subsidies for Medicaid and Low Income Recipients

Medicare recipients with low incomes and limited resources may qualify for additional assistance with the cost of prescription drugs.  Under complicated rules, seniors and other Medicare beneficiaries who qualify can have their monthly drug premiums waived, cost sharing requirements reduced, and coverage provided for the doughnut hole. 

The law establishes a number of subsidized categories for low income Medicare beneficiaries.  For ease of understanding, it is helpful to break these down into two major categories: dual eligibles and non-dual eligibles.  Each of these major categories has three sub-categories.  For purposes of Medicare Part D, dual eligibles are individuals who qualify for both Medicare and full Medicaid.  The dual eligible category apparently does not include persons who are receiving Medicaid under a Section 1115 waiver, like home care under the PDA 60+ Waiver program. 

Dual Eligibles.  The following sub-categories apply (in 2006) for dual eligibles (DE) who enroll in Medicare Part D: 

DE sub-category 1.  Dual eligibles who are Institutionalized: pay no premium, no deductible, no co-payments, and have no doughnut hole gap in coverage.

DE sub-category 2. Dual eligibles who are not institutionalized and who have incomes of up to 100% of poverty ($8,980 for an individual and $12,120 for a couple in 2003): pay no premium, no deductible, have no doughnut hole gap in coverage and pay co-payments of $1 for preferred (e.g. generic) drugs and $3 for other covered drugs.  Co-payments are indexed to drug inflation and cease when the participant reaches the catastrophic threshold ($3,600 out of pocket in 2006).

DE sub-category 3.  All other dual eligibles pay no premium, no deductible, have no doughnut hole gap in coverage and pay co-payments of $2 for preferred drugs and $5 for other covered drugs.  Co-payments are indexed to drug inflation and cease when the participant reaches the catastrophic threshold ($3,600 out of pocket in 2006).

There is no asset (resource) test for dual eligibles.

Existing Medicaid coverage will end for most drugs for "dual eligibles." Dual eligibles  will have to rely on their Medicare drug benefit, even if the Medicare formulary is more restricted and their preferred drugs are not covered.  Due to this potential for more limited formularies under Medicare, drug coverage may actually be reduced for those who previously had full coverage under Medicaid. 

Non-Dual Eligibles.  The new law institutes both income and asset ceilings for non-dual eligibles who participate in Part D. The following sub-categories apply (in 2006) for non-dual eligibles (NDE) who enroll in Medicare Part D:  

NDE sub-category 1.  Non-dual eligibles who have family incomes of less than 135 percent of the federal poverty level ($12,123 for an individual and $16,362 for a couple in 2003) and assets of under $6,000 individual and $9,000 couple: pay no premium, no deductible, have no doughnut hole gap in coverage and pay co-payments of $2 for preferred drugs and $5 for other drugs.  Co-payments are indexed to drug inflation and cease when the participant reaches the catastrophic threshold ($3,600 out of pocket in 2006).

NDE sub-category 2.  Non-dual eligibles who have family incomes of between 135 percent and 150% of the federal poverty level and assets of under $10,000 individual and $20,000 couple: pay a sliding scale premium, a $50 deductible, have reduced co-payments, have no doughnut hole gap in coverage and pay co-payments of $2 for preferred drugs and $5 for other drugs.  Co-payments are reduced when the participant reaches the catastrophic threshold ($3,600 out of pocket in 2006) to $2 for preferred and $5 for other covered drugs.

NDE sub-category 3.  Non-dual eligibles who do not fall into any other categories.  These remaining Part D enrollees will be subject to the deductibles, co-pays and doughnut hole which are described under standard (basic) Part D coverage above. 

Eligibility determinations for low income subsidies will be made under the state Medicaid plan (by the Department of Public Welfare) or by the Commissioner of Social Security. Income and resources will be determined using Supplemental Security Income (SSI) rules.  Resource levels will be indexed to the Consumer Price Index in years after 2006.  Eligibility for a subsidy begins in the month the individual applies for the subsidy.  Appeals from denials will be allowed, utilizing the procedures already established for Medicaid appeals for determinations made by the state Medicaid agency and Social Security procedures for determinations made by it. 

Prior to the Medicare Act of 2003, with minor exceptions, Medicare was not "means tested." Everyone had the same premiums, co-pays and deductibles and everyone received the same benefits.  Now, financial criteria will come into play in terms of premiums and co-payment requirements.  The addition of financial eligibility criteria to Medicare Part D makes it look much more like Medicaid.  This means testing will add significantly to Medicare's complexity and the difficulty participants will encounter in obtaining the benefits to which they are entitled.  It will also provide an added incentive for seniors to impoverish themselves through gifts or other techniques in order to protect their assets from health care costs. 

Effects on Medigap Insurance Policies

In order to encourage seniors to be cost conscious in using prescription drugs, the Medicare Act seeks to ensure that most seniors will feel some financial pain when they fill a prescription.  Thus, the law precludes consumers from purchasing Medicare Supplement ("Medigap") policies that would pay for their drug deductibles or co-payments, or cover the consumer for "doughnut-hole" costs. 

The law also prohibits the sale, after January 1, 2006 , of Medigap policies H, I, and J (which provide some prescription coverage) except to persons who already owned those policies on that date.  If a consumer retains a pre-existing Medigap policy that includes prescriptions, the Medigap coverage will be automatically amended to eliminate drugs when the consumer enrolls in a Part D plan.  The consumer who delays enrolling in Part D may incur a late enrollment charge.

In addition, in 2006 two new Medigap policies will be offered which will cover some of the cost-sharing that exists under Medicare Parts A and B.  The new Medigap policies will not cover prescription drugs.  

Effects on PACE/PACENET

Pennsylvania has recently revised and expanded its state-financed pharmaceutical assistance programs for seniors.  (For a discussion of the changes to PACE/PACENET see the December 18, 2003 Elder Care Law Alert  at http://www.paelderlaw.com/drugdiscount.html.)

How state drug plan benefits will integrate with Medicare Part D plans is not completely clear at the present time. It may be advantageous for some seniors to participate in both PACE and the Medicare drug benefit.  Any payments made by PACE for Medicare covered drugs will likely count towards the consumer's out-of-pocket thresholds for initial and catastrophic coverage.  However, the Medicare Act allows MA-PD and PDP plans some authority to limit the benefits provided by PACE if the state program would negatively impact the cost-effectiveness of the plans. 

It is likely that Pennsylvania will need to revisit its PACE/PACENET rules before the Medicare benefit takes effect in 2006.       


 

To subscribe or unsubscribe to the Elder Care Law Alert,

simply send your request to:

webmail@paelderlaw.com

 


Does Your Club Or Organization Need A Speaker?

If you are interested in having an attorney or geriatric planning specialist from

The Elder Law Firm of Marshall & Associates speak to your group, or at an upcoming event, please contact

our Public Education Coordinator,  Melissa Bottorf

at mbottorf@paelderlaw.com or 1-800-401-4552

 


*Attorney Marshall is certified as an Elder Law Attorney by the National Elder Law Foundation under authorization from the Pennsylvania Supreme Court

 

Elder Law Firm of Marshal & Associates

© 2000-2005 Marshall & Associates          www.paelderlaw.com